Collagen metabolism in gynecologic patients: Changes in the concentration of the aminoterminal propeptide of type III procollagen in serum
- 1 October 1990
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (4) , 1276-1281
- https://doi.org/10.1016/0002-9378(90)90707-e
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinomaCancer, 1990
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Laminin and type III procollagen peptide in human preovulatory follicular fluidFertility and Sterility, 1988
- Aminoterminal propeptide of type III procollagen in serum—an indicator of clinical behavior of advanced ovarian carcinoma?International Journal of Cancer, 1988
- Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgeryFertility and Sterility, 1988
- Collagen metabolism in normal and complicated pregnancy: changes in the aminoterminal propeptide of type III procollagen in serumEuropean Journal of Clinical Investigation, 1987
- Collagen Fibrillogenesis in Human SkinaAnnals of the New York Academy of Sciences, 1985
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979